Archive: 04/11/2013
Scientists discover new genetic mutation linked to eczema
Scientists collaborating on an international research project led by Trinity College Dublin and the University of Dundee have identified a new genetic mutation linked to the development of a type of eczema known as atopic ...
Nov 4, 2013
Two research groups find link between gene mutation and resistance to estrogen cancer therapy
(Medical Xpress)—Two teams of researchers, both made up of members from a wide variety of research institutions in the U.S. have independently come up with the same findings: a gene mutation in ESR1 (a gene that encodes ...
Nov 4, 2013
Studies show wide support for school-based health centers
Two new studies show that parents and students have highly positive views of school-based health centers (SBHCs) and suggest that they can serve as the `medical home' for an often low-income, at-risk population.
Nov 4, 2013
Canadian researchers discover how to measure quality of life for rare blood condition
A CHEO-led multi-site North American study, headed by Dr. Robert Klaassen, lead investigator at CHEO and associate professor in the University of Ottawa's Department of Pediatrics, has confirmed the validity and reliability ...
Nov 4, 2013
Stem cells linked to cognitive gain after brain injury in preclinical study
A stem cell therapy previously shown to reduce inflammation in the critical time window after traumatic brain injury also promotes lasting cognitive improvement, according to preclinical research led by Charles Cox, M.D., ...
Nov 4, 2013
California receives 'A' grade on Preterm Birth Report Card
California has improved its grade on the March of Dimes 2013 Premature Birth report card, moving from a 'B' grade in 2012 to an 'A' grade in 2013.
Nov 4, 2013
Cancer trends tell tale of insufficient prevention
Australians are now developing cancer at slightly higher rates but dying of the disease less often, according to University of Sydney research published in the Medical Journal of Australia (MJA).
Nov 4, 2013
Pharma giant Roche does deal to develop superbug killer
Pharmaceuticals giant Roche said on Monday that it had joined forces with fellow Swiss company Polyphor to develop an antibiotic to fight a superbug that has taken hold in hospitals.
Nov 4, 2013